Asymmetric dimethylarginine aggravates blood-retinal barrier breakdown of diabetic retinopathy via inhibition of intercellular communication in retinal pericytes
Asymmetric dimethylarginine aggravates blood-retinal barrier breakdown of diabetic retinopathy via inhibition of intercellular communication in retinal pericytes
复制标题
不对称二甲基精氨酸通过抑制视网膜周细胞的细胞间通讯加剧糖尿病视网膜病变的血-视网膜屏障破坏
DOI:
10.1007/s00726-019-02788-1
复制
发表时间:
2019-10-01
期刊:
影响因子:
3.5
通讯作者:
Jiang, Jun-Lin
中科院分区:
文献类型:
--
作者:
Huang, Chu-Yi;Zhou, Ting;Jiang, Jun-Lin
Blood-retinal barrier breakdown is the main pathological characteristics of diabetic retinopathy (DR). Asymmetric dimethylarginine (ADMA) was reported to be elevated in DR patients. In this study, we observed the dynamic profile of ADMA, retinal morphology and permeability of BRB at 2, 4 or 8 week of diabetic rats induced by a single intraperitoneal injection of streptozocin (60 mg/kg) and in cultured rat retinal pericytes pretreated with d-glucose (30 mM) for 1, 3, 5 and 7 days or ADMA (3, 10, 30 mu M) for 24, 48 and 72 h, trying to explore the effects of ADMA on blood-retinal barrier in DR. Gap junction intercellular communication (GJIC) and the expression of blood-retinal barrier-specific component connexin 43 (Cx43) were examined in diabetic rats or cultured retinal pericytes to elucidate whether ADMA impacted blood-retinal barrier function via damaging Cx43-GJIC. The results showed that with increasing duration of diabetes, the ultrastructure of blood-retinal barrier of diabetic rats appeared cell junction damage, apoptosis of retinal pericytes and breakdown of barrier successively. The increases in retinal permeability, ADMA levels and Cx43 expression, and abnormal GJIC were observed in diabetic rats and retinal pericytes exposed to d-glucose (30 mM). A glucose-like effect was seen using ADMA or another l-arginine analogue N-G-monomethyl-l-arginine or dimethylarginine dimethylaminohydrolases (DDAHs) siRNA, implicating that ADMA aggravated the breakdown of blood-retinal barrier via damaging Cx43-GJIC.